000623 吉林敖东
已收盘 05-13 15:00:00
资讯
新帖
简况
吉林敖东最新公告:控股子公司药品注射用丁二磺酸腺苷蛋氨酸通过一致性评价
证券之星 · 05-11 18:51
吉林敖东最新公告:控股子公司药品注射用丁二磺酸腺苷蛋氨酸通过一致性评价
股市必读:吉林敖东(000623)5月6日董秘有最新回复
证券之星 · 05-07
股市必读:吉林敖东(000623)5月6日董秘有最新回复
吉林敖东:构建全方位、多层次的投资者交流机制
证券之星 · 05-06
吉林敖东:构建全方位、多层次的投资者交流机制
吉林敖东(000623)2026年一季报简析:净利润同比增长67.56%,盈利能力上升
证券之星 · 05-01
吉林敖东(000623)2026年一季报简析:净利润同比增长67.56%,盈利能力上升
吉林敖东(000623.SZ)发布一季度业绩,归母净利润8.66亿元,增长67.56%
智通财经 · 04-29
吉林敖东(000623.SZ)发布一季度业绩,归母净利润8.66亿元,增长67.56%
吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%
证券之星 · 04-29
吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%
吉林敖东:已制定《未来三年(2024年-2026年)股东回报规划》
证券之星 · 04-27
吉林敖东:已制定《未来三年(2024年-2026年)股东回报规划》
吉林敖东(000623)2025年年报简析:净利润同比增长54.39%,盈利能力上升
证券之星 · 04-19
吉林敖东(000623)2025年年报简析:净利润同比增长54.39%,盈利能力上升
吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%
证券之星 · 04-18
吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%
吉林敖东最新公告:2025年净利润同比增长54.39%拟10派3元
证券之星 · 04-17
吉林敖东最新公告:2025年净利润同比增长54.39%拟10派3元
吉林敖东:坚持“医药健康+金融资本”双轮驱动发展模式
证券之星 · 04-14
吉林敖东:坚持“医药健康+金融资本”双轮驱动发展模式
吉林敖东:建立“统一指挥、分兵作战”的营销体系
证券之星 · 04-10
吉林敖东:建立“统一指挥、分兵作战”的营销体系
吉林敖东:以中医药传承创新为核心发展脉络
证券之星 · 04-10
吉林敖东:以中医药传承创新为核心发展脉络
吉林敖东(000623)股东敦化市金诚实业有限责任公司质押1445万股,占总股本1.21%
证券之星 · 04-09
吉林敖东(000623)股东敦化市金诚实业有限责任公司质押1445万股,占总股本1.21%
股市必读:吉林敖东(000623)4月1日董秘有最新回复
证券之星 · 04-02
股市必读:吉林敖东(000623)4月1日董秘有最新回复
3月23日吉林敖东跌5.56%,汇添富中证中药ETF基金重仓该股
证券之星 · 03-23
3月23日吉林敖东跌5.56%,汇添富中证中药ETF基金重仓该股
3月20日吉林敖东创60日新低,汇添富中证中药ETF基金重仓该股
证券之星 · 03-20
3月20日吉林敖东创60日新低,汇添富中证中药ETF基金重仓该股
吉林敖东:积极推进医药营销改革
证券之星 · 02-25
吉林敖东:积极推进医药营销改革
吉林敖东(000623)披露控股子公司获10个中药配方颗粒上市备案凭证,2月24日股价上涨1.25%
证券之星 · 02-24
吉林敖东(000623)披露控股子公司获10个中药配方颗粒上市备案凭证,2月24日股价上涨1.25%
吉林敖东(000623.SZ)子公司获得10个中药配方颗粒上市备案凭证
智通财经 · 02-12
吉林敖东(000623.SZ)子公司获得10个中药配方颗粒上市备案凭证
加载更多
公司概况
公司名称:
吉林敖东药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1996-10-28
主营业务:
吉林敖东药业集团股份有限公司的主营业务是中药、化学药品的研发、制造与销售。公司的主要产品是安神补脑液、小儿柴桂退热口服液、养血饮口服液、注射用核糖核酸II、肾复康片、血府逐瘀口服液、少腹逐瘀颗粒、龟芪参口服液、注射用盐酸平阳霉素、伸筋片、注射用丁二磺酸腺苷蛋氨酸、金芪降糖胶囊、注射用盐酸地尔硫卓、脑心舒口服液、生脉饮口服液、孕康颗粒、感冒清热胶囊、复方金银花颗粒、羚贝止咳糖浆、利脑心胶囊、维D2乳酸钙片、鼻炎宁颗粒、磷酸奥司他韦胶囊、金莲花口服液、注射用卡络磺钠、杜蛭丸、断血流胶囊。
发行价格:
7.20
{"stockData":{"symbol":"000623","market":"SZ","secType":"STK","nameCN":"吉林敖东","latestPrice":18.69,"timestamp":1778655786000,"preClose":18.88,"halted":0,"volume":13037956,"delay":0,"changeRate":-0.0101,"floatShares":1191000000,"shares":1196000000,"eps":2.2949,"marketStatus":"已收盘","change":-0.19,"latestTime":"05-13 15:00:00","open":18.92,"high":19.01,"low":18.6,"amount":244000000,"amplitude":0.0217,"askPrice":18.7,"askSize":198,"bidPrice":18.69,"bidSize":296,"shortable":0,"etf":0,"ttmEps":2.2949,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778722200000},"marketStatusCode":5,"adr":0,"adjPreClose":18.88,"symbolType":"stock","openAndCloseTimeList":[[1778635800000,1778643000000],[1778648400000,1778655600000]],"highLimit":20.77,"lowLimit":16.99,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1195895387,"isCdr":false,"pbRate":0.72,"roa":"--","peRate":8.144146,"roe":"2.79%","epsLYR":2.0416,"committee":-0.140645,"marketValue":22351000000,"turnoverRate":0.0109,"status":1,"floatMarketCap":22260000000},"requestUrl":"/m/hq/s/000623","defaultTab":"news","newsList":[{"id":"2634886382","title":"吉林敖东最新公告:控股子公司药品注射用丁二磺酸腺苷蛋氨酸通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2634886382","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634886382?lang=zh_cn&edition=full","pubTime":"2026-05-11 18:51","pubTimestamp":1778496690,"startTime":"0","endTime":"0","summary":"吉林敖东(000623.SZ)公告称,公司控股子公司延吉药业收到国家药监局下发的“注射用丁二磺酸腺苷蛋氨酸”《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价,适用于肝硬化前和肝硬化所致肝内胆汁淤积及妊娠期肝内胆汁淤积。本次获批有利于扩大市场份额,但预计短期内不会对公司业绩产生重大影响。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100028929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0086","BK0188","BK0012","BK0028","BK0201","BK0239","000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153824","title":"股市必读:吉林敖东(000623)5月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633153824?lang=zh_cn&edition=full","pubTime":"2026-05-07 01:40","pubTimestamp":1778089219,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘,吉林敖东报收于19.0元,上涨0.69%,换手率1.31%,成交量15.62万手,成交额2.97亿元。董秘最新回复投资者: 董秘您好,目前公司二级市场市场关注度与机构持仓活跃度一般,请问公司是否计划主动开展机构沟通工作,通过投资者路演、线上线下调研、专项交流等方式,向公募、私募等机构传递公司经营基本面、业务布局及长期成长逻辑,提升机构认可度与配置意愿?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700001175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0188","BK0239","BK0012","BK0201","000623","BK0028","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633324188","title":"吉林敖东:构建全方位、多层次的投资者交流机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2633324188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633324188?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:54","pubTimestamp":1778057658,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东05月06日在投资者关系平台上答复投资者关心的问题。公司构建全方位、多层次的投资者交流机制,通过举办年度业绩说明会、参与网上集体接待日、组织投资者实地调研、及时回复互动易投资者问答、畅通投资者热线及电子邮箱沟通渠道等多种方式,全面、准确、及时传递公司经营信息和企业价值,增进投资者对公司的了解和认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600025391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0086","BK0074","BK0201","000623","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632566052","title":"吉林敖东(000623)2026年一季报简析:净利润同比增长67.56%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632566052","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632566052?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:35","pubTimestamp":1777588551,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期吉林敖东发布2026年一季报。截至本报告期末,公司营业总收入5.14亿元,同比下降17.43%,归母净利润8.66亿元,同比上升67.56%。本报告期吉林敖东盈利能力上升,毛利率同比增幅2.76%,净利率同比增幅102.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100006479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631136065","title":"吉林敖东(000623.SZ)发布一季度业绩,归母净利润8.66亿元,增长67.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631136065","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631136065?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:22","pubTimestamp":1777461743,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林敖东(000623.SZ)发布2026年第一季度报告,该公司营业收入为5.14亿元,同比减少17.43%。归属于上市公司股东的净利润为8.66亿元,同比增长67.56%。归属于上市公司股东的扣除非经常性损益的净利润为8.69亿元,同比增长78.05%。基本每股收益为0.7387元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"吉林敖东(000623.SZ)发布一季度业绩,归母净利润8.66亿元,增长67.56%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596123","title":"吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596123","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596123?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:46","pubTimestamp":1777456013,"startTime":"0","endTime":"0","summary":"证券之星消息,近日吉林敖东披露,截至2026年3月31日公司股东户数为6.39万户,较12月31日增加2194.0户,增幅为3.56%。在中药行业个股中,吉林敖东股东户数高于行业平均水平,截至3月31日,中药行业平均股东户数为5.36万户。从股价来看,2025年12月31日至2026年3月31日,吉林敖东区间跌幅为9.88%,在此期间股东户数增加2194.0户,增幅为3.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0074","BK0086","000623","BK0239","BK0188","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630452364","title":"吉林敖东:已制定《未来三年(2024年-2026年)股东回报规划》","url":"https://stock-news.laohu8.com/highlight/detail?id=2630452364","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630452364?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:48","pubTimestamp":1777283305,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东04月27日在投资者关系平台上答复投资者关心的问题。近两年来,公司推行中期、年度两次现金分红,进一步提高分红比例与频次,增强股东回报的稳定性和可预期性。同时,公司已制定《未来三年股东回报规划》,通过明确、稳定的分红政策,强化公司长期投资价值,持续回报广大投资者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0012","BK0074","BK0086","BK0239","BK0188","BK0028","000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628754727","title":"吉林敖东(000623)2025年年报简析:净利润同比增长54.39%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2628754727","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628754727?lang=zh_cn&edition=full","pubTime":"2026-04-19 06:10","pubTimestamp":1776550239,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期吉林敖东发布2025年年报。截至本报告期末,公司营业总收入23.35亿元,同比下降10.55%,归母净利润23.95亿元,同比上升54.39%。本报告期吉林敖东盈利能力上升,毛利率同比增幅19.68%,净利率同比增幅73.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628732969","title":"吉林敖东(000623)3月31日股东户数6.39万户,较上期增加3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628732969","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628732969?lang=zh_cn&edition=full","pubTime":"2026-04-18 17:05","pubTimestamp":1776503103,"startTime":"0","endTime":"0","summary":"证券之星消息,近日吉林敖东披露,截至2026年3月31日公司股东户数为6.39万户,较12月31日增加2194.0户,增幅为3.56%。在中药行业个股中,吉林敖东股东户数高于行业平均水平,截至3月31日,中药行业平均股东户数为5.35万户。从股价来看,2025年12月31日至2026年3月31日,吉林敖东区间跌幅为9.88%,在此期间股东户数增加2194.0户,增幅为3.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800018638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0239","BK0201","BK0074","BK0086","000623","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628203556","title":"吉林敖东最新公告:2025年净利润同比增长54.39%拟10派3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628203556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628203556?lang=zh_cn&edition=full","pubTime":"2026-04-17 19:19","pubTimestamp":1776424756,"startTime":"0","endTime":"0","summary":"吉林敖东(000623.SZ)披露年报,2025年实现营业收入23.35亿元,同比下降10.55%;归母净利润23.95亿元,同比增长54.39%;基本每股收益2.04元。公司拟每10股派发现金红利3元(含税)。报告期内,公司医药主业各细分领域协同发展,金融投资板块收益显著提升,其中广发证券按权益法核算投资收益同比增长46.53%,叠加公允价值变动收益,成为业绩重要支持。注:公司Q4净利润1.35亿,Q3净利润9.79亿,据此计算,Q4净利润环比下降86%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700038837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627138924","title":"吉林敖东:坚持“医药健康+金融资本”双轮驱动发展模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2627138924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627138924?lang=zh_cn&edition=full","pubTime":"2026-04-14 15:27","pubTimestamp":1776151625,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东04月14日在投资者关系平台上答复投资者关心的问题。公司积极应对经济环境及行业政策的变化,坚持“医药健康+金融资本”双轮驱动发展模式,聚焦医药健康主业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400018981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0239","BK0201","BK0188","BK0028","000623","BK0086","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626165471","title":"吉林敖东:建立“统一指挥、分兵作战”的营销体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2626165471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626165471?lang=zh_cn&edition=full","pubTime":"2026-04-10 22:33","pubTimestamp":1775831593,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东04月10日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000041722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0188","BK0201","BK0239","BK0012","BK0074","000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626116542","title":"吉林敖东:以中医药传承创新为核心发展脉络","url":"https://stock-news.laohu8.com/highlight/detail?id=2626116542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626116542?lang=zh_cn&edition=full","pubTime":"2026-04-10 22:33","pubTimestamp":1775831593,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东04月10日在投资者关系平台上答复投资者关心的问题。公司聚焦医药主业,持续提升经营质量,以中医药传承创新为核心发展脉络,深度融合传统理念与现代科技,构建了“自主创新+开放协作”的研发模式,通过自主研发、合作开发及产品引进等多维路径,持续研发涵盖经典名方、化药制剂、大健康产品的多元矩阵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000041723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0086","BK0074","BK0028","BK0201","000623","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626183091","title":"吉林敖东(000623)股东敦化市金诚实业有限责任公司质押1445万股,占总股本1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2626183091","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626183091?lang=zh_cn&edition=full","pubTime":"2026-04-09 18:22","pubTimestamp":1775730157,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东4月9日公开信息显示,股东敦化市金诚实业有限责任公司向国泰海通证券股份有限公司合计质押1445.0万股,占总股本1.21%。质押详情见下表:截止本公告日,股东敦化市金诚实业有限责任公司已累计质押股份1.09亿股,占其持股总数的33.44%。吉林敖东主营业务:主要从事中成药、生物化学药研发、制造和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900031158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0028","BK0012","BK0188","BK0086","BK0201","000623","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624480795","title":"股市必读:吉林敖东(000623)4月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2624480795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624480795?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:45","pubTimestamp":1775061915,"startTime":"0","endTime":"0","summary":"截至2026年4月1日收盘,吉林敖东报收于17.95元,上涨1.99%,换手率0.8%,成交量9.58万手,成交额1.71亿元。董秘最新回复投资者: 广发证券业绩出来了,公司持有股份的收益就超过了公司预告的年报收益。是公司主营业务亏损了吗?公司2025年度业绩具体情况请以公司计划于2026年4月18日发布的2025年度报告数据为准。当日关注点来自交易信息汇总:4月1日主力资金净流入281.8万元,显示主力对个股短期态度偏积极。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0028","BK0239","BK0188","BK0074","BK0086","BK0012","000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621377648","title":"3月23日吉林敖东跌5.56%,汇添富中证中药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621377648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621377648?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:45","pubTimestamp":1774255547,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日吉林敖东跌5.56%创60日新低,收盘报16.98元,换手率1.69%,成交量20.1万手,成交额3.46亿元。重仓吉林敖东的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为汇添富基金的汇添富中证中药ETF。汇添富中证中药ETF目前规模为24.52亿元,最新净值1.0252,较上一交易日上涨0.05%,近一年下跌2.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","159647","560080","BK0086","BK0201","BK0074","BK0012","000623"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620786685","title":"3月20日吉林敖东创60日新低,汇添富中证中药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620786685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620786685?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:20","pubTimestamp":1773994814,"startTime":"0","endTime":"0","summary":"证券之星消息,3月20日吉林敖东创60日新低,收盘报17.98元,当日跌1.1%,换手率0.79%,成交量9.41万手,成交额1.71亿元。重仓吉林敖东的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为汇添富基金的汇添富中证中药ETF。汇添富中证中药ETF目前规模为24.52亿元,最新净值1.0247,较上一交易日下跌1.23%,近一年下跌2.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159647","BK0012","BK0028","BK0086","560080","BK0074","BK0201","000623","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614653705","title":"吉林敖东:积极推进医药营销改革","url":"https://stock-news.laohu8.com/highlight/detail?id=2614653705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614653705?lang=zh_cn&edition=full","pubTime":"2026-02-25 15:27","pubTimestamp":1772004433,"startTime":"0","endTime":"0","summary":"证券之星消息,吉林敖东02月25日在投资者关系平台上答复投资者关心的问题。投资者提问:2025年7月,腾讯健康与康美药业签署战略合作协议后,经营有了较好改观。请问吉林敖东是否有引进有先进经营理念的战略合作者的想法?目前公司正积极推进医药营销改革,通过整合各营销板块、组建营销事业群,优化管理体系、形成发展合力、统一资源,实现营销突破,助力公司高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500018642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0012","BK1161","BK0074","000623","BK0188","09939","BK0239","BK0028","BK1574","BK0086","BK0201","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613138727","title":"吉林敖东(000623)披露控股子公司获10个中药配方颗粒上市备案凭证,2月24日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613138727","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613138727?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:25","pubTimestamp":1771932335,"startTime":"0","endTime":"0","summary":"吉林敖东药业集团股份有限公司近日披露《关于控股子公司获得中药配方颗粒上市备案凭证的自愿性信息披露公告》。公告显示,公司控股子公司吉林敖东延边药业股份有限公司近日获得10个中药配方颗粒上市备案凭证,涉及龙葵、天葵子、醋艾炭等产品。截至目前,延边药业已累计获得535个中药配方颗粒上市备案凭证。该事项对公司拓展中药配方颗粒业务具有重要意义,有助于增强企业核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400039140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0201","BK0239","BK0012","BK0074","BK0188","000623","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610948699","title":"吉林敖东(000623.SZ)子公司获得10个中药配方颗粒上市备案凭证","url":"https://stock-news.laohu8.com/highlight/detail?id=2610948699","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610948699?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:19","pubTimestamp":1770884375,"startTime":"0","endTime":"0","summary":"智通财经APP讯,吉林敖东(000623.SZ)发布公告,近日,公司控股子公司吉林敖东延边药业股份有限公司(以下简称“延边药业”)获得10个《中药配方颗粒上市备案凭证》。延边药业作为公司核心层企业,在中药领域具有一定优势,截至本公告刊登之日已累计获得535个《中药配方颗粒上市备案凭证》,对公司拓展中药配方颗粒业务具有重要意义,为公司持续发展创造了有利条件,进一步增强了企业的核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0201","000623","BK0086","BK0239","BK0188","BK0028","BK0074"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778665359987,"stockEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0351},{"period":"3month","weight":-0.0011},{"period":"6month","weight":-0.1157},{"period":"1year","weight":0.1912},{"period":"ytd","weight":-0.0333}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0573},{"period":"3month","weight":0.02},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.2509},{"period":"ytd","weight":0.0619}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"吉林敖东药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"63885人(较上一季度增加3.56%)","perCapita":"18643股","listingDate":"1996-10-28","address":"吉林省延边朝鲜族自治州敦化市敖东大街2158号","registeredCapital":"119589万元","survey":" 吉林敖东药业集团股份有限公司的主营业务是中药、化学药品的研发、制造与销售。公司的主要产品是安神补脑液、小儿柴桂退热口服液、养血饮口服液、注射用核糖核酸II、肾复康片、血府逐瘀口服液、少腹逐瘀颗粒、龟芪参口服液、注射用盐酸平阳霉素、伸筋片、注射用丁二磺酸腺苷蛋氨酸、金芪降糖胶囊、注射用盐酸地尔硫卓、脑心舒口服液、生脉饮口服液、孕康颗粒、感冒清热胶囊、复方金银花颗粒、羚贝止咳糖浆、利脑心胶囊、维D2乳酸钙片、鼻炎宁颗粒、磷酸奥司他韦胶囊、金莲花口服液、注射用卡络磺钠、杜蛭丸、断血流胶囊。","listedPrice":7.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉林敖东,000623,吉林敖东股票,吉林敖东股票老虎,吉林敖东股票老虎国际,吉林敖东行情,吉林敖东股票行情,吉林敖东股价,吉林敖东股市,吉林敖东股票价格,吉林敖东股票交易,吉林敖东股票购买,吉林敖东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉林敖东(000623)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉林敖东(000623)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}